| Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review JM Malinowski, S Bolesta Clinical therapeutics 22 (10), 1151-1168, 2000 | 215 | 2000 |
| Position paper on critical care pharmacy services: 2020 update I Lat, C Paciullo, MJ Daley, R MacLaren, S Bolesta, J McCann, ... Critical care medicine 48 (9), e813-e834, 2020 | 149 | 2020 |
| Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry JP Domecq, A Lal, CR Sheldrick, VK Kumar, K Boman, S Bolesta, ... Critical care medicine 49 (3), 437-448, 2021 | 144 | 2021 |
| Interprofessional education among student health professionals using human patient simulation S Bolesta, JV Chmil American Journal of Pharmaceutical Education 78 (5), 94, 2014 | 123 | 2014 |
| The viral infection and respiratory illness universal study (VIRUS): an international registry of coronavirus 2019-related critical illness AJ Walkey, VK Kumar, MO Harhay, S Bolesta, V Bansal, O Gajic, ... Critical care explorations 2 (4), e0113, 2020 | 108 | 2020 |
| Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors S Bolesta, SL Haber Annals of Pharmacotherapy 36 (2), 331-333, 2002 | 93 | 2002 |
| Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: the society of critical care medicine discovery … AJ Walkey, RC Sheldrick, R Kashyap, VK Kumar, K Boman, S Bolesta, ... Critical care medicine 48 (11), e1038-e1044, 2020 | 61 | 2020 |
| An opinion paper outlining recommendations for training, credentialing, and documenting and justifying critical care pharmacy services W Dager, S Bolesta, G Brophy, K Dell, A Gerlach, J Kristeller, S Micek, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (8 …, 2011 | 58 | 2011 |
| Drug class combination–associated acute kidney injury RM Rivosecchi, JA Kellum, JF Dasta, MJ Armahizer, S Bolesta, ... Annals of Pharmacotherapy 50 (11), 953-972, 2016 | 52 | 2016 |
| Pharmacist instruction of physical assessment for pharmacy students S Bolesta, DP Trombetta, DS Longyhore American Journal of Pharmaceutical Education 75 (2), 29, 2011 | 37 | 2011 |
| Perceived motivating factors and barriers for the completion of postgraduate training among American pharmacy students prior to beginning advanced pharmacy practice experiences DA Hammond, DR Oyler, JW Devlin, JT Painter, S Bolesta, JM Swanson, ... American journal of pharmaceutical education 81 (5), 90, 2017 | 35 | 2017 |
| Preoperative statins and acute kidney injury after cardiac surgery: utilization of a consensus definition of acute kidney injury S Bolesta, LM Uhrin, JR Guzek Annals of Pharmacotherapy 45 (1), 23-30, 2011 | 28 | 2011 |
| Society of critical care medicine discovery viral infection and respiratory illness universal study (VIRUS): COVID-19 Registry Investigator Group. Outcomes of patients with … JP Domecq, A Lal, CR Sheldrick, VK Kumar, K Boman, S Bolesta, ... Crit Care Med 49 (3), 437-448, 2021 | 27 | 2021 |
| Position paper on critical care pharmacy services (executive summary): 2020 update I Lat, C Paciullo, MJ Daley, R MacLaren, S Bolesta, J McCann, ... Journal of the American College of Clinical Pharmacy 3 (7), 1380-1389, 2020 | 26 | 2020 |
| Severe acute respiratory syndrome–associated coronavirus 2 infection and organ dysfunction in the ICU: Opportunities for translational research PA Verhoef, S Kannan, JL Sturgill, EW Tucker, PE Morris, AC Miller, ... Critical care explorations 3 (3), e0374, 2021 | 24 | 2021 |
| Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings NM Acquisto, CJ Beavers, S Bolesta, MS Buckley, KF Dobbins, CK Finch, ... Journal of the American College of Clinical Pharmacy 4 (12), 1601-1617, 2021 | 23 | 2021 |
| Hospital variation in management and outcomes of acute respiratory distress syndrome due to COVID-19 SW Johnson, MA Garcia, EKQ Sisson, CR Sheldrick, VK Kumar, K Boman, ... Critical care explorations 4 (2), e0638, 2022 | 21 | 2022 |
| International analgesia and sedation weaning and withdrawal practices in critically ill adults: the adult iatrogenic withdrawal study in the ICU S Bolesta, L Burry, MM Perreault, C Gélinas, KE Smith, R Eadie, FC Carini, ... Critical care medicine 51 (11), 1502-1514, 2023 | 18 | 2023 |
| Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review S Bolesta, BP Roslund American Journal of Health-System Pharmacy 65 (1), 37-41, 2008 | 17 | 2008 |
| Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study R Eadie, CA McKenzie, D Hadfield, NJ Kalk, S Bolesta, M Dempster, ... International journal of clinical pharmacy 45 (5), 1167-1175, 2023 | 14 | 2023 |
